727 Congenital absence of NOS3 potentiates left ventricular dysfunction and increases mortality in doxorubicin and trastuzumab mediated cardiomyopathy
| Autor: | Zeglinski, M., Bohonis, S., Lerner, J., Sharma, A., Thliveris, J., Singal, P.K., Jassal, D.S. |
|---|---|
| Zdroj: | In Canadian Journal of Cardiology September-October 2011 27(5) Supplement:S329-S330 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect